Troy's Trojan Income fund manager Francis Brooke has sold his position in Aberdeen Asset Management after its share price doubled in the space of 12 months.
Brooke (pictured) told Investment Week last year the asset manager was transforming into a "cashflow machine" as it began to up its dividends, but he has now disposed of his holding after Aberdeen's strong share price run. "The holding in Aberdeen Asset Management was sold having more than doubled in value since purchase," said the manager, who has subsequently topped up holdings in Nestle, Britvic, GlaxoSmithKline and BAT. Aberdeen shares were trading at 212p apiece at the start of 2012, the point at which Brooke added a position equivalent to 1% of his £1bn portfolio. The shares ...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes